GlassScriptPhysician profile
Sherry Lee Brooks
NPI 1750462776
$3,017.46
in general payments reported to CMS, 2019-2025
17 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $337 · 2021: $577 · 2022: $704 · 2023: $479 · 2024: $337 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $562.95 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $430.04 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $330.68 | 2024-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Axsome Therapeutics, INC. | $235.16 | 2023-2024 | Auvelity |
| Neurocrine Biosciences, INC. | $234.84 | 2022-2023 | Ingrezza |
| Abbvie INC. | $220.64 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $176.87 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $148.98 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.19 | 2019 | |
| Allergan, INC. | $124.24 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $121.71 | 2020 | |
| Ironshore Pharmaceuticals INC. | $121.35 | 2020 | |
| Idorsia Pharmaceuticals US INC | $121.30 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $23.08 | 2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Phadia US INC. | $16.38 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12.46 | 2019 | |
| Ethicon US, LLC | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.